Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Opzelura
Pharma
Incyte's Opzelura scores in hidradenitis suppurativa study
The company presented positive data from a phase 2 study in mild-to-moderate hidradenitis suppurativa at the AAD's annual meeting on Sunday.
Zoey Becker
Mar 11, 2024 1:58pm
Leo Pharma builds its case for JAK inhibitor cream delgocitinib
Jan 24, 2024 10:36am
Leo unveils detailed results on JAK cream win in hand eczema
Oct 13, 2023 11:05am
Incyte taps actor to help tell the stories of eczema patients
Oct 12, 2023 11:38am
Incyte's Opzelura hits goal in eczema trial in young kids
Jul 12, 2023 10:30am
Dermavant bolsters Vtama's case for approval in eczema
May 16, 2023 8:25am